HopeStage
Study directory

Addiction studies

Addiction involves difficulty controlling substance use or a behaviour despite its harmful effects on everyday life.

Back to overview
More filters: keywords, city, remote
713studies shown
Showing 517-528 of 713
Other study type icon
RecruitingNCT07455526

Facilitation to Increase Tobacco Treatment

Official study title

External Facilitation to Expand Reach of Tobacco Treatment to SMI Veterans

In Baltimore
AddictionInterventional study
Countries
United States
Sponsor
VA Office of Research and Development (Government agency)
Drug study icon
RecruitingACTRN12614000054617

Providing adult smokers, who smoke at least one cigarette per day, the opportunity to sample a range of nicotine replacement therapies (NRTs) for Addiction

Official study title

A pilot uncontrolled single arm non-randomised open-label trial of the acceptability and effect on motivation to quit and compliance with use of nicotine replacement therapy of supplying nicotine replacement therapies to smokers in community locations regardless of their motivation to quit smoking.

In New Zealand
AddictionInterventional studyAges 18+
Countries
New Zealand
Sponsor
Ministry of Health
Drug study icon
RecruitingNCT06655883

Suvorexant for Addiction

What is this study about?

Researchers are comparing Suvorexant and placebo, tracking side effects to assess safety in people with opioid dependence.

Multiple locations, including Garden Grove
AddictionMedication studyAges 18–70
Countries
United States
Sponsor
Merck Sharp & Dohme LLC
Behavioral study icon
RecruitingNCT07587359

A Unique, Co-Designed Family-Based Therapy

Official study title

A Unique, Co-Designed Family-Based Therapy for Women With Opioid Use Disorder and Justice-Involvement

In Columbus
AddictionBehavioural studyAges 18+
Countries
United States
Sponsor
Ohio State University
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.